Table 2.
Treatment patterns within one year of osteoporosis diagnosis
| All patients (n = 10,292) | ||
|---|---|---|
| n | % | |
| No treatment | 7689 | 74.7 |
| Bisphosphonates | 2422 | 23.5 |
| Alendronate | 1265 | 12.3 |
| Zoledronic acid | 720 | 7.0 |
| Risedronate | 312 | 3.0 |
| Ibandronate | 125 | 1.2 |
| Non-bisphosphonates | 181 | 1.8 |
| Raloxifene | 97 | 0.9 |
| Strontium ranelate | 43 | 0.4 |
| Calcitonin | 41 | 0.4 |
| Teriparatide | 0 | 0.0 |
| Parathyroid hormone | 0 | 0.0 |
| Mean time until treatment (days) | Mean | SD |
| Bisphosphonate initiation (n = 2422) | 48.9 | 81.2 |
| Non-bisphosphonate initiation (n = 181) | 40.8 | 78.4 |
SD standard deviation